213 related articles for article (PubMed ID: 16952547)
1. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis.
Henckaerts L; Jaspers M; Van Steenbergen W; Vliegen L; Fevery J; Nuytten H; Roskams T; Rutgeerts P; Cassiman JJ; Vermeire S; Cuppens H
J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
4. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.
Tischendorf JJ; Hecker H; Krüger M; Manns MP; Meier PN
Am J Gastroenterol; 2007 Jan; 102(1):107-14. PubMed ID: 17037993
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
Yang X; Cullen SN; Li JH; Chapman RW; Jewell DP
J Hepatol; 2004 Mar; 40(3):375-9. PubMed ID: 15123348
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
[TBL] [Abstract][Full Text] [Related]
7. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
8. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kam I
Liver Transpl; 2008 Feb; 14(2):181-5. PubMed ID: 18236392
[TBL] [Abstract][Full Text] [Related]
9. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
[TBL] [Abstract][Full Text] [Related]
10. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
Boberg KM; Rocca G; Egeland T; Bergquist A; Broomé U; Caballeria L; Chapman R; Hultcrantz R; Mitchell S; Pares A; Rosina F; Schrumpf E
Hepatology; 2002 Mar; 35(3):652-7. PubMed ID: 11870380
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
Okolicsanyi L; Fabris L; Viaggi S; Carulli N; Podda M; Ricci G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
[TBL] [Abstract][Full Text] [Related]
13. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
[TBL] [Abstract][Full Text] [Related]
15. Primary sclerosing cholangitis in children: a long-term follow-up study.
Feldstein AE; Perrault J; El-Youssif M; Lindor KD; Freese DK; Angulo P
Hepatology; 2003 Jul; 38(1):210-7. PubMed ID: 12830004
[TBL] [Abstract][Full Text] [Related]
16. The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis.
Shetty K; Rybicki L; Carey WD
Hepatology; 1997 May; 25(5):1049-53. PubMed ID: 9141416
[TBL] [Abstract][Full Text] [Related]
17. The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy.
Castaño G; Burgueño A; Fernández Gianotti T; Pirola CJ; Sookoian S
Aliment Pharmacol Ther; 2010 Mar; 31(5):583-92. PubMed ID: 19958310
[TBL] [Abstract][Full Text] [Related]
18. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
19. No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.
Wiencke K; Boberg KM; Donaldson P; Harbo H; Ling V; Schrumpf E; Spurkland A
Scand J Gastroenterol; 2006 May; 41(5):586-91. PubMed ID: 16638702
[TBL] [Abstract][Full Text] [Related]
20. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
Kim WR; Poterucha JJ; Wiesner RH; LaRusso NF; Lindor KD; Petz J; Therneau TM; Malinchoc M; Dickson ER
Hepatology; 1999 Jun; 29(6):1643-8. PubMed ID: 10347102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
